Cardiovascular benefit of cholesterol-lowering therapy: does improved endothelial vasodilator function matter?
- 22 August 2000
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 102 (8) , 820-2
- https://doi.org/10.1161/01.cir.102.8.820
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effect of Cholesterol-Lowering Therapy on Coronary Endothelial Vasomotor Function in Patients With Coronary Artery DiseaseCirculation, 2000
- Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery DiseaseNew England Journal of Medicine, 1999
- Long-Term Anti-Ischemic Effects of Angiotensin-Converting Enzyme Inhibition in Patients After Myocardial InfarctionJournal of the American College of Cardiology, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.Journal of Clinical Investigation, 1995
- The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary VasomotionNew England Journal of Medicine, 1995
- Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1995
- Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patientsThe Lancet, 1993
- Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1986
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980